13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001746382
Total reported value
$47.5M
$47.5M
1 檔
1.3%
As reported in its official Q3 2025 Form 13F filing, Altium Capital Management LLC's tracked investment portfolio stood at $47.5M with 1 total positions.
In Q3 2025, Altium Capital Management LLC adopted a defensive or profit-taking posture, trimming 0 positions and completely liquidating 23 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CYTXEUR | Plus Therapeutics Inc | Stock-Other | 100.00% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CYTXEUR | Plus Therapeutics Inc | — | NEW | New buy |
| 2 | ZVRA | Zevra Therapeutics Inc | — | EXIT | Sold out |
| 3 | ALNY | Alnylam Pharmaceuticals Inc | — | EXIT | Sold out |
| 4 | EOLS | Evolus Inc | — | EXIT | Sold out |
| 5 | XTNT | Xtant Medical Holdings Inc | — | EXIT | Sold out |
| 6 | ✓ | Avadel Pharmaceuticals PLC ADR | — | EXIT | Sold out |
| 7 | XENE | Xenon Pharmaceuticals Inc | — | EXIT | Sold out |
| 8 | CTNM | Contineum Therapeutics Inc-a | — | EXIT | Sold out |
| 9 | PROF | Profound Medical CORP | — | EXIT | Sold out |
| 10 | EPIEUR | Essa Pharma Inc | — | EXIT | Sold out |
| 11 | SKYE | Skye Bioscience Inc | — | EXIT | Sold out |
| 12 | ACOG | Alpha Cognition Inc | — | EXIT | Sold out |
| 13 | RZLT | Rezolute Inc | — | EXIT | Sold out |
| 14 | NKTREUR | Nektar Therapeutics | — | EXIT | Sold out |
| 15 | AVR | Anteris Technologies Global | — | EXIT | Sold out |
| 16 | LRMR | Larimar Therapeutics Inc | — | EXIT | Sold out |
| 17 | PMNEUR | Promis Neurosciences Inc | — | EXIT | Sold out |
| 18 | ✓ | Envveno Medical CORP | — | EXIT | Sold out |
| 19 | GBS1EUR | Gbs Inc | — | EXIT | Sold out |
| 20 | KPTI | Karyopharm Therapeutics Inc | — | EXIT | Sold out |
| 21 | ✓ | Sharps Technology Inc | — | EXIT | Sold out |
| 22 | ✓ | — | EXIT | Sold out | |
| 23 | ✓ | — | EXIT | Sold out | |
| 24 | SRXH | Srx Health Solutions Inc | — | EXIT | Sold out |
According to official SEC Form 13F filings, Altium Capital Management LLC reported a total U.S. public equity portfolio value of $47.5M across 1 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including CYTXEUR) accounted for 1.3% of total reported equity market value during Q3 2025.
Top New Position Initiated
CYTXEUR
市值: $628.3M
Top Position Liquidated / Trimmed
ZVRA
前期市值: $9.6M
During Q3 2025, Altium Capital Management LLC's top holdings by market value included CYTXEUR (100.0%). The largest single position, CYTXEUR, represented 100.0% of total portfolio value.
In Q3 2025, Altium Capital Management LLC made 24 total portfolio adjustments, initiating 1 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 23 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.